David Gall

David Gall is the chief executive of the NRFC, an investment fund aimed at supporting the commercialization of medical research in Australia. His focus on providing patient capital helps companies like Synchron to scale their innovative technologies without the pressure of high-return expectations, thereby fostering a sustainable ecosystem for medical advancements.